Endoscopic surgery versus intensity-modulated radiotherapy in locally advanced recurrent nasopharyngeal carcinoma: a multicenter, case-matched comparison

被引:1
|
作者
Liu, Yibin [1 ]
Huang, Nan [2 ]
Gao, Junxiao [3 ]
He, Bin [4 ]
Huang, Hongming [1 ]
Wan, Liangcai [3 ]
Cai, Qinming [3 ]
Zhu, Zhenchao [3 ]
Zhou, Suizi [1 ]
Wang, Jing [2 ]
Wang, Xiaohui [2 ]
Qiu, Qianhui [1 ]
Han, Fei [2 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Otolaryngol Head & Neck Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Guangdong Prov Clin Res Ctr Canc, Dept Radiat Oncol,State Key Lab Oncol South China,, Guangzhou, Peoples R China
[3] Southern Med Univ, Zhujiang Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou, Peoples R China
[4] Wuzhou Red Cross Hosp, Dept Otolaryngol & Head & Neck Surg, Wuzhou, Peoples R China
关键词
Nasopharyngeal carcinoma; Recurrent; Surgery; Radiotherapy; RADIATION-THERAPY; SALVAGE; REIRRADIATION; SURVIVAL; MAXILLARY; OUTCOMES; MODEL;
D O I
10.1186/s40463-023-00656-3
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundThe management of locally advanced recurrent nasopharyngeal carcinoma (rNPC) is challenging. The objective of our study was to compare salvage endoscopic nasopharyngectomy (ENPG) with intensity-modulated radiotherapy (IMRT) in clinical outcomes and complications of locally advanced rNPC.MethodsPatients with histologically confirmed rNPC in rT3-4N0-3M0 stages were retrospectively enrolled between January 2013 and December 2019 in this multicenter, case-matched study. The baseline clinicopathological characteristics of patients were balanced by propensity score matching between the ENPG and IMRT groups. ENPG was performed in patients with easily or potentially resectable tumors. The oncological outcomes as well as treatment-related complications were compared between two groups.ResultsA total of 176 patients were enrolled and 106 patients were matched. The ENPG group (n = 53) and the IMRT group (n = 53) showed comparable outcomes in the 3-year overall survival rate (68.4% vs. 65.4%, P = 0.401), cancer-specific survival rate (80.9% vs. 74.4%, P = 0.076), locoregional failure-free survival rate (36.6% vs. 45.3%, P = 0.076), and progression-free survival rate (27.5% vs. 32.3%, P = 0.216). The incidence of severe treatment-related complications of patients in the ENPG group was lower than that in the IMRT group (37.7% vs. 67.9%, P = 0.002). The most common complications were post perioperative hemorrhage (13.2%) in ENPG group and temporal lobe necrosis (47.2%) in IMRT group, respectively.ConclusionSalvage ENPG exhibits comparable efficacy but less toxicities than IMRT in carefully screened patients with locally advanced rNPC, which may be a new choice of local treatment.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Intensity-modulated or stereotactic reirradiation in recurrent nasopharyngeal carcinoma
    Roeder, F.
    Zwicker, F.
    Timke, C.
    Muenter, M. W.
    Huber, P. E.
    Debus, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 88 - 88
  • [42] Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
    Aftab, Omer
    Liao, Shufang
    Zhang, Rongjun
    Tang, Nan
    Luo, Meiqing
    Zhang, Bin
    Shahi, Sanjeev
    Rai, Raju
    Ali, Jazib
    Jiang, Wei
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [43] Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
    Omer Aftab
    Shufang Liao
    Rongjun Zhang
    Nan Tang
    Meiqing Luo
    Bin Zhang
    Sanjeev Shahi
    Raju Rai
    Jazib Ali
    Wei Jiang
    Radiation Oncology, 15
  • [44] Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma
    You, Rui
    Sun, Rui
    Hua, Yi-Jun
    Li, Chao-Feng
    Li, Ji-Bin
    Zou, Xiong
    Yang, Qi
    Liu, You-Ping
    Zhang, Yi-Nuan
    Yu, Tao
    Cao, Jing-Yu
    Zhang, Meng-Xia
    Jiang, Rou
    Mo, Hao-Yuan
    Guo, Ling
    Cao, Ka-Jia
    Lin, Ai-Hua
    Qian, Chao-Nan
    Sun, Ying
    Ma, Jun
    Chen, Ming-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1265 - 1276
  • [45] Volume and Dosimetric Variations During Two-Phase Adaptive Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma
    Wang, Rui-hao
    Zhang, Shu-xu
    Zhou, Ling-hong
    Zhang, Guo-qian
    Yu, Hui
    Lin, Xiao-dan
    Lin, Shengqu
    BIO-MEDICAL MATERIALS AND ENGINEERING, 2014, 24 (01) : 1217 - 1225
  • [46] Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    YuXiang He
    Ying Wang
    PengFei Cao
    Lin Shen
    YaJie Zhao
    ZiJian Zhang
    DengMing Chen
    TuBao Yang
    XinQiong Huang
    Zhou Qin
    YouYi Dai
    LiangFang Shen
    ChineseJournalofCancer, 2016, 35 (12) : 725 - 734
  • [47] A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy
    Penggang Bai
    Xing Weng
    Kerun Quan
    Jihong Chen
    Yitao Dai
    Yuanji Xu
    Fasheng Lin
    Jing Zhong
    Tianming Wu
    Chuanben Chen
    Radiation Oncology, 15
  • [48] A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy
    Bai, Penggang
    Weng, Xing
    Quan, Kerun
    Chen, Jihong
    Dai, Yitao
    Xu, Yuanji
    Lin, Fasheng
    Zhong, Jing
    Wu, Tianming
    Chen, Chuanben
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [49] Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy
    Chen, Chuanben
    Chen, Taojun
    Huang, Chaoxiong
    Wang, Jing
    Fei, Zhaodong
    MEDICINE, 2017, 96 (44)
  • [50] Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD-1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma
    Shang, Kai
    He, Qianyong
    Xu, Xinyu
    Luo, Xunyan
    Zhao, Chaofen
    Liu, Lina
    Li, Zhuoling
    Li, Yuanyuan
    Jin, Feng
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2025, 21 : 15 - 25